Daiichi Sankyo to Boost ADC Cancer Drug Production, COO Says

BNN BloombergOct 10 20:58 ET

Express News | Esperion Therapeutics Shares Are Trading Higher After the Company Announced That Its European Partner, Daiichi Sankyo Europe, Reported Final 2-year Follow-up Data From the German Cohort of the Multinational, European Observational MILOS Study

BenzingaOct 2 12:39 ET

AstraZeneca, Daiichi Sankyo's Breast Cancer Treatment Enhertu Accepted for US Priority Review

MT NewswiresOct 1 02:30 ET

Daiichi To Go Ex-Dividend On September 27th, 2024 With 26 JPY Dividend Per Share

September 26th (Japan Standard Time) - $Daiichi(7643.JP)$ is trading ex-dividend on September 27th, 2024.Shareholders of record on September 30th, 2024 will receive 26 JPY dividend per share. The ex-

Moomoo NewsSep 25 21:00 ET

Datopotamab Deruxtecan Final Overall Survival Results Reported in Patients With Metastatic HR Positive, HER2 Low or Negative Breast Cancer in TROPION-Breast01 Phase 3 Trial

BusinesswireSep 23 02:00 ET

NHS England to Offer Daiichi Sankyo's Quizartinib for AML

Yahoo FinanceSep 20 04:12 ET